• Logo
  • SBMUJournals

Research Paper: Effectiveness of Corticosteroid Therapy for Caustic Esophageal Injury

Seyed Hadi Mirhashemi, Mohammad Hadizadeh-Neisanghalb, Mohammad Salehi, Pooya Rostami
116

Views

PDF

Abstract

Background: Delayed caustic injury complications are common, especially in developing countries, and several treatments have been proposed to prevent the resulting esophageal strictures so far. Although inflammatory nature of caustic injury makes the anti-inflammatory agents a viable option, few studies have investigated these agents. High-dose corticosteroids therapy for reduction of stricture formation in the esophagus after the ingestion of caustic material is still a controversial topic. In this regard, this study aimed to determine the impact of high doses of methylprednisolone in preventing esophageal stricture.
Methods: A total of 112 patients with grade II esophageal caustic injury, diagnosed by esophagogastroscopy within 24 hours of injury, were enrolled in our study. The treatment group (n=44) received methylprednisolone (1 g/d for 3 days), pantoprazole, ceftriaxone, and metronidazole and the control group (n=58) received the same regimen excluding methylprednisolone. Endoscopic and radiologic findings were used to compare the severity of the damage to the esophagus and stomach between the two groups.
Results: After 8 months of follow-up, stricture development was observed in 3 (5.6%) patients in the treatment group and in 11 (19%) patients in the control group. The difference was statistically significant (P=0.038). The gastric outlet obstruction was observed in 4 (7.4%) patients in the treatment group and in 19 (32.7%) patients in the control group. Again, the difference was statistically significant (P<0.05). There were not any side effects due to the high doses of methylprednisolone in the study group.
Conclusion: High doses of methylprednisolone can prevent the development of esophageal stricture in grade II of caustic injury.


Keywords

Caustics, Steroids, Esophageal stenosis

References

Chirica M, Resche Rigon M, Bongrand NM, Zohar S, Halimi B, Gornet JM, et al. Surgery for caustic injuries of the upper gastrointestinal tract. Annals of Surgery. 2012; 256(6):994-1001. [DOI:10.1097/SLA.0b013e3182583fb2]

Zargar SA, Kochhar R, Mehta S, Mehta SK. The role of fiberoptic endoscopy in the management of corrosive ingestion and modified endoscopic classification of burns. Gastrointestinal Endoscopy. 1991; 37(2):165-9. [DOI:10.1016/S0016-5107[91)70678-0]

Contini S, Scarpignato C. Caustic injury of the upper gastrointestinal tract: A comprehensive review. World Journal of Gastroenterology. 2013; 19(25):3918-30. [DOI:10.3748/wjg.v19.i25.3918] [PMCID]

Meena B, Narayan K, Goyal G, Sultania S, Nijhawan S. Corrosive injuries of the upper gastrointestinal tract. Journal of Digestive Endoscopy. 2017; 8(4):165-9. [DOI:10.4103/jde.JDE_24_16]

Ananthakrishnan N, Parthasarathy G, Kate V. Chronic corrosive injuries of the stomach-a single unit experience of 109 patients over thirty years. World Journal of Surgery. 2010; 34(4):758-64. [DOI:10.1007/s00268-010-0393-8] [PMID]

Gupta V, Wig JD, Kochhar R, Sinha SK, Nagi B, Doley RP, et al. Surgical management of gastric cicatrisation resulting from corrosive ingestion. International Journal of Surgery. 2009; 7(3):257-61. [DOI:10.1016/j.ijsu.2009.04.009] [PMID]

Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proceedings of the National Academy of Sciences. 1992; 89(21):9991-5. [DOI:10.1073/pnas.89.21.9991]

Barnes PJ. Mechanisms and resistance in glucocorticoid control of inflammation. The Journal of Steroid Biochemistry and Molecular Biology. 2010; 120(2):76-85. [DOI:10.1016/j.jsbmb.2010.02.018] [PMID]

Wightman RS, Read KB, Hoffman RS. Evidence-based management of caustic exposures in the emergency department. Emergency Medicine Practice. 2016; 18(5):1-17. [PMID]

Pelclová D, Navrátil T. Do corticosteroids prevent oesophageal stricture after corrosive ingestion. Toxicological Reviews. 2005; 24(2):125-9. [DOI:10.2165/00139709-200524020-00006] [PMID]

Katibe R, Abdelgadir I, McGrogan P, Akobeng AK. Corticosteroids for preventing caustic esophageal strictures: Systematic review and meta-analysis. Journal of Pediatric Gastroenterology and Nutrition. 2018; 66(6):898-902. [DOI:10.1097/MPG.0000000000001852] [PMID]

Katz A, Kluger Y. Caustic material ingestion injuries-paradigm shift in diagnosis and treatment. Health Care Current Reviews. 2015; 3(152):2-6. [DOI:10.4172/2375-4273.1000152]

Usta M, Erkan T, Cokugras FC, Urganci N, Onal Z, Gulcan M, et al. High doses of methylprednisolone in the management of caustic esophageal burns. Pediatrics. 2014; 133(6):E1518-24. [DOI:10.1542/peds.2013-3331] [PMID]

Bautista A, Varela R, Villanueva A, Estevez E, Tojo R, Cadranel S. Effects of prednisolone and dexamethasone in children with alkali burns of the oesophagus. European Journal of Pediatric Surgery. 1996; 6(4):198-203. [DOI:10.1055/s-2008-1066507] [PMID]

Anderson KD, Rouse TM, Randolph JG. A controlled trial of corticosteroids in children with corrosive injury of the esophagus. The New England Journal of Medicine. 1990; 323(10):637-40. [DOI:10.1056/NEJM199009063231004] [PMID]

Boukthir S, Fetni I, Mrad SM, Mongalgi MA, Debbabi A, Barsaoui S. [High doses of steroids in the management of caustic esophageal burns in children]. Archives de Pediatrie. 2004; 11(1):13-7. [DOI:10.1016/j.arcped.2003.10.011] [PMID]

Mazigh Mrad S, Boukthir S, Sfaihi L, Fetni I, Dabbabi A, Zouari B, et al. [Therapeutic management and clinical course of severe caustic oesophageal burns in children treated with methyl-prednisolone. Experience at a digestive endoscopic unit (French)]. La Tunisie Médicale. 2004; 82(10):951-7. [PMID]

Fulton JA, Hoffman RS. Steroids in second degree caustic burns of the esophagus: A systematic pooled analysis of fifty years of human data: 1956-2006. Clinical Toxicology. 2007; 45(4):402-8. [DOI:10.1080/15563650701285420] [PMID]




DOI: https://doi.org/10.22037/ijmtfm.v8i4(Summer).22814